Qube Research & Technologies LTD Zoetis Inc. Transaction History

Qube Research & Technologies LTD

  • $93.8 Billion
  • Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Zoetis Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,138,701 shares of ZTS stock, worth $164 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,138,701
Previous 267,716 325.34%
Holding current value
$164 Million
Previous $44.1 Million 302.87%
% of portfolio
0.19%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$144.41 - $170.3 $126 Million - $148 Million
870,985 Added 325.34%
1,138,701 $178 Million
Q1 2025

May 15, 2025
SELL
$156.48 - $175.67 $40.3 Million - $45.2 Million
-257,412 Reduced 49.02%
267,716 $44.1 Million
Q4 2024

Feb 14, 2025
BUY
$162.24 - $194.42 $21.1 Million - $25.3 Million
129,998 Added 32.9%
525,128 $85.6 Million
Q3 2024

Nov 14, 2024
BUY
$172.58 - $196.48 $67.5 Million - $76.9 Million
391,337 Added 10317.35%
395,130 $77.2 Million
Q2 2024

Aug 14, 2024
SELL
$145.54 - $178.83 $301 Million - $370 Million
-2,071,267 Reduced 99.82%
3,793 $657,000
Q1 2024

May 14, 2024
BUY
$165.67 - $199.94 $273 Million - $330 Million
1,650,590 Added 388.86%
2,075,060 $351 Million
Q4 2023

Feb 13, 2024
BUY
$151.44 - $200.09 $442,204 - $584,262
2,920 Added 0.69%
424,470 $83.8 Million
Q3 2023

Nov 13, 2023
SELL
$167.14 - $192.77 $32.2 Million - $37.1 Million
-192,681 Reduced 31.37%
421,550 $73.3 Million
Q2 2023

Aug 14, 2023
BUY
$160.94 - $186.23 $46.5 Million - $53.8 Million
288,882 Added 88.79%
614,231 $106 Million
Q1 2023

May 15, 2023
BUY
$145.48 - $175.02 $27.7 Million - $33.3 Million
190,288 Added 140.89%
325,349 $54.2 Million
Q4 2022

Feb 14, 2023
SELL
$131.14 - $157.47 $6.18 Million - $7.42 Million
-47,147 Reduced 25.88%
135,061 $19.8 Million
Q3 2022

Nov 14, 2022
BUY
$148.29 - $182.55 $21.6 Million - $26.6 Million
145,693 Added 398.99%
182,208 $27 Million
Q2 2022

Aug 15, 2022
SELL
$155.97 - $200.09 $71.2 Million - $91.3 Million
-456,333 Reduced 92.59%
36,515 $6.28 Million
Q1 2022

May 09, 2022
BUY
$181.39 - $234.03 $89.4 Million - $115 Million
492,848 New
492,848 $92.9 Million
Q4 2021

Feb 01, 2022
SELL
$193.69 - $247.03 $8.77 Million - $11.2 Million
-45,291 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$189.29 - $209.69 $4.1 Million - $4.55 Million
21,677 Added 91.8%
45,291 $8.79 Million
Q2 2021

Aug 13, 2021
BUY
$155.9 - $187.99 $3.68 Million - $4.44 Million
23,614 New
23,614 $4.4 Million
Q1 2021

May 14, 2021
SELL
$144.0 - $169.39 $791,136 - $930,628
-5,494 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$157.07 - $174.35 $3.26 Million - $3.61 Million
-20,729 Reduced 79.05%
5,494 $909,000
Q3 2020

Nov 12, 2020
SELL
$137.1 - $165.37 $12.6 Million - $15.2 Million
-91,787 Reduced 77.78%
26,223 $4.34 Million
Q2 2020

Aug 14, 2020
BUY
$111.92 - $142.53 $12.6 Million - $16 Million
112,399 Added 2003.19%
118,010 $16.2 Million
Q1 2020

May 15, 2020
BUY
$92.66 - $144.94 $519,915 - $813,258
5,611 New
5,611 $660,000
Q4 2019

Feb 13, 2020
SELL
$116.25 - $133.25 $577,646 - $662,119
-4,969 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$112.57 - $128.43 $559,360 - $638,168
4,969 New
4,969 $619,000
Q2 2019

Aug 02, 2019
SELL
$97.98 - $114.28 $821,268 - $957,894
-8,382 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$81.56 - $100.67 $683,635 - $843,815
8,382 New
8,382 $844,000
Q4 2018

Feb 14, 2019
SELL
$79.28 - $95.27 $511,197 - $614,300
-6,448 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$83.5 - $93.23 $319,304 - $356,511
3,824 Added 145.73%
6,448 $590,000
Q2 2018

Aug 14, 2018
BUY
$79.9 - $89.2 $209,657 - $234,060
2,624 New
2,624 $224,000

Others Institutions Holding ZTS

# of Institutions
2,124
Shares Held
430M
Call Options Held
1.47M
Put Options Held
1.45M
View Full List

About Zoetis Inc.

ZTS Quotes by TradingView
  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $67.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email